Journal of Computer-Aided Molecular Design

, Volume 15, Issue 3, pp 247–258 | Cite as

An improved nicotinic pharmacophore and a stereoselective CoMFA-model for nicotinic agonists acting at the central nicotinic acetylcholine receptors labelled by [3H]-N-methylcarbamylcholine

  • Janne E. Tønder
  • Preben H. Olesen
  • John Bondo Hansen
  • Mikael Begtrup
  • Ingrid Pettersson


A study of a series of compounds with agonistic effect at the α4β2 nicotinic acetylcholine receptors resulted in an improved pharmacophore model as well as a CoMFA model. The pharmacophore was composed of three pharmacophoric elements: (1) a site point (a) corresponding to a protonated nitrogen atom, (2) a site point (b) corresponding to an electronegative atom capable of forming a hydrogen bond, and (3) the centre of a heteroaromatic ring or a C=O bond (c). The pharmacophoric elements were related by the following parameters: (a–b) 7.3–8.0 Å, (a–c) 6.5–7.4 Å, and the angle between the two distance vectors (Δbac) 30.4–35.8°. In addition to this, a stereoselective CoMFA model was developed, which showed good predictability even for compound classes not present in the training set.

CoMFA model 3D-QSAR nicotinic agonists pharmacophore model 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Beers, W.H. and Reich, E., Nature, 228 (1970) 917.Google Scholar
  2. 2.
    Sheridan, R.P., Nilakantan, R., Dixon, J.S. and Venkataraghavan, R., J. Med. Chem., 29 (1986) 899.Google Scholar
  3. 3.
    Manallack, D.T., Gallagher, T. and Livingstone, D.J., in Devillers, J. (Ed), Neural Networks in QSAR and Drug Design, Academic Press, London, 1996, pp. 177-208.Google Scholar
  4. 4.
    Holladay, M.W., Lebold, S.A. and Lin, N.-H., Drug Dev. Res., 35 (1995) 191.Google Scholar
  5. 5.
    Glennon, R.A. and Dukat, M., Med. Chem. Res. (1996) 465.Google Scholar
  6. 6.
    Hacksell, U. and Mellin, C., Prog. Brain Res., 79 (1989) 95.Google Scholar
  7. 7.
    Wright, E., Gallagher, T., Sharples, C.G.V. and Wonnacott, S., Bioorg. Med. Chem. Lett., 7 (1997) 2867.Google Scholar
  8. 8.
    Zhang, X., Stjernlöf, P., Adem, A. and Nordberg, A., Eur. J. Pharmacol., 135 (1987) 457.Google Scholar
  9. 9.
    Dukat, M., Damaj, M.I., Glassco, W., Dumas, D., May, E.L., Martin, B.R. and Glennon, R.A., Med. Chem. Res., 4 (1993) 131.Google Scholar
  10. 10.
    Abreo, M.A., Lin, N.-H., Garvey, D.S., Gunn, D.E., Hettinger, A.M., Wasicak, J.T., Pavlik, P.A., Martin, Y.C., Donnelly-Roberts, D.L., Anderson, D.J., Sullivan, J.P., Williams, M., Arneric, S.P. and Holladay, M.W., J. Med. Chem., 39 (1996) 817.Google Scholar
  11. 11.
    Koren, A.O., Horti, A.G., Mukhin, A.G., Gundisch, D., Kimes, A.S., Dannals, R.F. and London, E.D., J. Med. Chem., 41 (1998) 3690.Google Scholar
  12. 12.
    Cheng, Y.-X., Dukat, M., Dowd, M., Fiedler, W., Martin, B., Damaj, M.I. and Glennon, R.A., Eur. J. Med. Chem., 34 (1999) 177.Google Scholar
  13. 13.
    TØnder, J.E., Hansen, J.B., Begtrup, M., Pettersson, I., Rimvall, K., Christensen, B., Ehrbar, U. and Olesen, P.H., J. Med. Chem., 42 (1999) 4970.Google Scholar
  14. 14.
    Glennon, R.A., Herndon, J.L. and Dukat, M., Med. Chem. Res., 4 (1994) 461.Google Scholar
  15. 15.
    Holladay, M.W., Dart, M.J. and Lynch, J.K., J. Med. Chem., 40 (1997) 4169.Google Scholar
  16. 16.
    Okazawa, A., Akamatsu, M., Ohoka, A., Nishiwaki, H., Cho, W.-J., Nakagawa, Y., Nishimura, K. and Ueno, T., Pestic. Sci., 54 (1998) 134.Google Scholar
  17. 17.
    Sukekawa, M. and Nakayama, A., J. Pestic. Sci., 24 (1999) 38.Google Scholar
  18. 18.
    Olesen, P.H., TØnder, J.E., Hansen, J.B., Hansen, H.C. and Rimvall, K., Bioorganic and Medicinal Chemistry, submitted (2000).Google Scholar
  19. 19.
    Mohamadi, F., Richards, N.G.J., Guida, W.C., Liskamp, R., Lipton, M., Caufield, C., Chang, G., Hendrickson, T. and Still, W.C., J. Comput. Chem., 11 (1990) 440.Google Scholar
  20. 20.
    Halgren, T.A., J. Comput. Chem., 17 (1996) 490.Google Scholar
  21. 21.
    Halgren, T.A., J. Comput. Chem., 17 (1996) 520.Google Scholar
  22. 22.
    Halgren, T.A., J. Comput. Chem., 17 (1996) 553.Google Scholar
  23. 23.
    Halgren, T.A., J. Comput. Chem., 17 (1996) 587.Google Scholar
  24. 24.
    Hasel, W., Hendrickson, T.F. and Still, W.C., Tetrahedron Comput. Method., 1 (1988) 103.Google Scholar
  25. 25.
    Still, W.C., Tempczyk, A., Hawley, R.C. and Hendrickson, T., J. Am. Chem. Soc., 112 (1990) 6127.Google Scholar
  26. 26.
    Tripos Inc., 1699 South Hanley Road, St. Louis, Missouri, 63144, USAGoogle Scholar
  27. 27.
    Dukat, M., Fiedler, W., Dumas, D., Damaj, I., Martin, B.R., Rosecrans, J.A., James, J.R. and Glennon, R.A., Eur. J. Med. Chem., 31 (1996) 875.Google Scholar
  28. 28.
    Badio, B., Garraffo, H.M., Plummer, C.V., Padgett, W.L. and Daly, J.W., Eur. J. Pharmacol., 321 (1997) 189.Google Scholar
  29. 29.
    Badio, B. and Daly, J.W., Mol. Pharmacol., 45 (1994) 563.Google Scholar
  30. 30.
    Kim, K.H., Greco, G. and Novellino, E., Perspectives in Drug Discovery and Design, 12/13/14 (1998) 257.Google Scholar

Copyright information

© Kluwer Academic Publishers 2001

Authors and Affiliations

  • Janne E. Tønder
    • 1
  • Preben H. Olesen
    • 1
  • John Bondo Hansen
    • 1
  • Mikael Begtrup
    • 2
  • Ingrid Pettersson
    • 1
  1. 1.Health Care DiscoveryNovo Nordisk A/SMåløvDenmark
  2. 2.Department of Medicinal ChemistryRoyal Danish School of PharmacyCopenhagenDenmark

Personalised recommendations